Literature DB >> 33603745

Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF.

Hong-Wei Sun1,2, Wen-Chao Wu1, Hai-Tian Chen3, Yi-Tuo Xu1,2, Yan-Yan Yang1,2, Jing Chen1, Xing-Juan Yu1, Zilian Wang3, Ze-Yu Shuang1,4, Limin Zheng1,2.   

Abstract

Solid tumors are often challenged by hypoxic and nutrient-deprived tumor microenvironments (TME) as tumors progress, due to limited perfusion and rapid nutrient consumption. While cancer cells can demonstrate the ability to survive in nutrient-deprived conditions through multiple intrinsic alterations, it is poorly understood how nutrient-deprived cancer cells co-opt the TME to promote cancer cell survival and tumor progression. In the present study, we found that glutamine deprivation markedly potentiated the expression of G-CSF and GM-CSF in mouse mammary cancer cells. The IRE1α-JNK pathway, which is activated by glutamine starvation, was found to be important for the upregulation of these cytokines. G-CSF and GM-CSF are well-known facilitators of myelopoiesis and mobilization of hematopoietic progenitor cells (HPC). Consistently, as tumors progressed, we found that several myeloid HPC compartments were gradually decreased in the bone marrow but were significantly increased in the spleen. Mechanistically, the HPC-maintaining capacity of the bone marrow was significantly impaired in tumor-bearing mice, with lower expression of HPC maintaining genes (i.e., CXCL12, SCF, ANGPT1, and VCAM1), and reduced levels of mesenchymal stem cells and CXCL12-producing cells. Furthermore, the mobilized HPCs that displayed the capacity for myelopoiesis were also found to accumulate in tumor tissue. Tumor-infiltrating HPCs were highly proliferative and served as important sources of immunosuppressive myeloid-derived suppressor cells (MDSCs) in the TME. Our work has identified an important role for glutamine starvation in regulating the expression of G-CSF and GM-CSF, and in facilitating the generation of immunosuppressive MDSCs in breast cancer.
Copyright © 2021 Sun, Wu, Chen, Xu, Yang, Chen, Yu, Wang, Shuang and Zheng.

Entities:  

Keywords:  G-CSF; GM-CSF; MDSC; bone marrow; glutamine

Mesh:

Substances:

Year:  2021        PMID: 33603745      PMCID: PMC7884351          DOI: 10.3389/fimmu.2020.616367

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  60 in total

Review 1.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 2.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Authors:  Vinit Kumar; Sima Patel; Evgenii Tcyganov; Dmitry I Gabrilovich
Journal:  Trends Immunol       Date:  2016-02-06       Impact factor: 16.687

3.  Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.

Authors:  Yuliya Pylayeva-Gupta; Kyoung Eun Lee; Cristina H Hajdu; George Miller; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

4.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

5.  Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages.

Authors:  Tsuyoshi Osawa; Rika Tsuchida; Masashi Muramatsu; Teppei Shimamura; Feng Wang; Jun-ichi Suehiro; Yasuharu Kanki; Youichiro Wada; Yasuhito Yuasa; Hiroyuki Aburatani; Satoru Miyano; Takashi Minami; Tatsuhiko Kodama; Masabumi Shibuya
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

6.  PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin.

Authors:  Yoshio Katayama; Andrés Hidalgo; Barbara C Furie; Dietmar Vestweber; Bruce Furie; Paul S Frenette
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

7.  Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis.

Authors:  Chong Wu; Huiheng Ning; Mingyu Liu; Jie Lin; Shufeng Luo; Wenjie Zhu; Jing Xu; Wen-Chao Wu; Jing Liang; Chun-Kui Shao; Jiaqi Ren; Bin Wei; Jun Cui; Min-Shan Chen; Limin Zheng
Journal:  J Clin Invest       Date:  2018-07-09       Impact factor: 14.808

8.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Authors:  Bin Zhang; Zhijun Wang; Liangliang Wu; Meng Zhang; Wei Li; Jianhua Ding; Jun Zhu; Huafeng Wei; Ke Zhao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

Authors:  Jaekyoung Son; Costas A Lyssiotis; Haoqiang Ying; Xiaoxu Wang; Sujun Hua; Matteo Ligorio; Rushika M Perera; Cristina R Ferrone; Edouard Mullarky; Ng Shyh-Chang; Ya'an Kang; Jason B Fleming; Nabeel Bardeesy; John M Asara; Marcia C Haigis; Ronald A DePinho; Lewis C Cantley; Alec C Kimmelman
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962

10.  Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Authors:  Thomas Welte; Ik Sun Kim; Lin Tian; Xia Gao; Hai Wang; June Li; Xue B Holdman; Jason I Herschkowitz; Adam Pond; Guorui Xie; Sarah Kurley; Tuan Nguyen; Lan Liao; Lacey E Dobrolecki; Lan Pang; Qianxing Mo; Dean P Edwards; Shixia Huang; Li Xin; Jianming Xu; Yi Li; Michael T Lewis; Tian Wang; Thomas F Westbrook; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Nat Cell Biol       Date:  2016-05-16       Impact factor: 28.824

View more
  11 in total

1.  Identification of a 5-gene-risk score model for predicting luminal A-invasive lobular breast cancer survival.

Authors:  Yi-Huan Chen; Tao-Feng Zhang; Yi-Yuan Liu; Jie-Hua Zheng; Wei-Xun Lin; Yao-Kun Chen; Jie-Hui Cai; Juan Zou; Zhi-Yang Li
Journal:  Genetica       Date:  2022-05-10       Impact factor: 1.633

2.  Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth.

Authors:  Xuan Pei; Kai-Yue Li; Yuan Shen; Jin-Tao Li; Ming-Zhu Lei; Cai-Yun Fang; Hao-Jie Lu; Hui-Juan Yang; Wenyu Wen; Miao Yin; Jia Qu; Qun-Ying Lei
Journal:  Sci China Life Sci       Date:  2022-03-25       Impact factor: 10.372

3.  3D bioprinted white adipose model forin vitrostudy of cancer-associated cachexia induced adipose tissue remodeling.

Authors:  Wen Xue; Seok-Yeong Yu; Mitchell Kuss; Yunfan Kong; Wen Shi; Soonkyu Chung; So-Youn Kim; Bin Duan
Journal:  Biofabrication       Date:  2022-05-26       Impact factor: 11.061

Review 4.  Myelopoiesis during Solid Cancers and Strategies for Immunotherapy.

Authors:  Tyler J Wildes; Bayli DiVita Dean; Catherine T Flores
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

Review 5.  The Metabolic Control of Myeloid Cells in the Tumor Microenvironment.

Authors:  Eloise Ramel; Sebastian Lillo; Boutaina Daher; Marina Fioleau; Thomas Daubon; Maya Saleh
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

Review 6.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828

Review 7.  Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives.

Authors:  Thomas Boyer; Céline Blaye; Nicolas Larmonier; Charlotte Domblides
Journal:  Cells       Date:  2022-02-05       Impact factor: 6.600

Review 8.  Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer.

Authors:  Yunchang Li; Lanlin Hu; Xinhao Peng; Huasheng Xu; Bo Tang; Chuan Xu
Journal:  Cancer Drug Resist       Date:  2022-02-08

9.  Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.

Authors:  Jingwen Zou; Kunpeng Du; Shaohua Li; Lianghe Lu; Jie Mei; Wenping Lin; Min Deng; Wei Wei; Rongping Guo
Journal:  Genes (Basel)       Date:  2021-08-25       Impact factor: 4.096

10.  Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis.

Authors:  Yue Qiu; Yirui Cao; Guowei Tu; Jiawei Li; Ying Su; Fang Fang; Xuepeng Zhang; Jing Cang; Ruiming Rong; Zhe Luo
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.